quote from nanobiotech news;
.. These two transactions may be the harbinger of more major deals to come, says Rezos. "We have been discussions with a number of large corporations in pharma, biotech and medical devices around the world, and these negotiations take many months, "he notes. "The important thing is that with Itochu deal, and now this agreement with a large pharma firm, we feel it will speed up the negotiations we've been having with these other companies over the past 15 months. We expect to see more of these announced --certainly in the first quarter of 2005."
- Forums
- ASX - By Stock
- PSD
- more analysts research
PSD
psivida limited
more analysts research, page-2
Featured News
Add PSD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online